Schedule 13G ownership disclosure

C4 Therapeutics Inc

Security class unavailable · CUSIP: 12529R107

Event date: 2024-01-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-009888
Form type
SC 13G
Filer
C4 Therapeutics, Inc.
CIK
CIK 1662579
Filed
Feb 05, 2024
Reporting period
Jan 26, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub